Tag: Eli Lilly and Co

June 29, 2026

Key Medicare Advantage Coverage Changes Begin July 1 – What Seniors Need to Know

June 27, 2026

Micron Shares Fall Despite Earnings Boost as Inflation Fears Ease

June 13, 2026

Novo Nordisk and Eli Lilly Dominance Under Threat as Drugmakers Bet Big on Obesity Treatment

April 12, 2026

GLP-1 Drugs Could Boost Apparel Retail Spending by $13 Billion Annually

February 6, 2026

Trump Launches TrumpRx: Will New Website Lower Drug Costs?

February 5, 2026

Lilly Outpaces Novo Nordisk in Obesity Drug Market: 2026 Outlook

February 4, 2026

Eli Lilly Blows Past Estimates as Zepbound & Mounjaro Demand Soars

February 3, 2026

Stock Market Today: Nvidia, Eli Lilly, Novo Nordisk & Earnings Preview

February 3, 2026

Novo Nordisk Stock Drops as Sales Forecast Declines Amid Competition

January 31, 2026

Lilly, Alphabet, Amazon Earnings & Job Market Update

January 17, 2026

Novo Nordisk Shares Rise: Wegovy Obesity Pill Launch Success

January 12, 2026

Amazon Pharmacy Now Offers Wegovy Weight Loss Pill

January 10, 2026

Obesity Pills 2026: Novo Nordisk & Eli Lilly Lead the Way

January 9, 2026

Abivax Stock Surge: Biotech Takeover Target

January 1, 2026

Novo Nordisk Wegovy Ozempic 2026 Legal Battle

December 27, 2025

Novo Nordisk’s GLP-1 Pill Approved by FDA for Obesity